CEREVEL THERAPEUTICS HOLDINGS, INC. FORM OF INDEMNIFICATION AGREEMENT (DIRECTORS)Form of Indemnification Agreement • November 2nd, 2020 • Cerevel Therapeutics Holdings, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of [Date] by and between Cerevel Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), and [Director Name] (“Indemnitee”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 2nd, 2020 • Cerevel Therapeutics Holdings, Inc. • Pharmaceutical preparations • Massachusetts
This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of March 16, 2019 by and between Cerevel Therapeutics, LLC (the “Company”) and John Renger (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 2nd, 2020 • Cerevel Therapeutics Holdings, Inc. • Pharmaceutical preparations • Massachusetts
This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of November 26, 2018 by and between Cerevel Therapeutics, LLC (the “Company”) and Ramiro Sanchez (the “Executive”).
AMENDED AND RESTATED REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT BY AND AMONG CEREVEL THERAPEUTICS HOLDINGS, INC. AND THE STOCKHOLDERS PARTY HERETO DATED AS OF OCTOBER 27, 2020Registration and Shareholder Rights Agreement • November 2nd, 2020 • Cerevel Therapeutics Holdings, Inc. • Pharmaceutical preparations • Delaware
This AMENDED AND RESTATED REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT (as it may be amended from time to time in accordance with the terms hereof, the “Agreement”), dated as of October 27, 2020 is made by and among:
CAMBRIDGE CROSSING (PARCEL JK) LEASE FOR CEREVEL THERAPEUTICS, LLC FOR A PORTION OF THE BUILDING KNOWN AS 222 JACOBS STREET CAMBRIDGE, MASSACHUSETTSCerevel Therapeutics Holdings, Inc. • November 2nd, 2020 • Pharmaceutical preparations • Massachusetts
This Lease (the “Lease”) is hereby entered into as of the Lease Date set forth below by and between the undersigned Landlord and Tenant.
INCENTIVE STOCK OPTION AGREEMENT UNDER THE CEREVEL THERAPEUTICS HOLDINGS, INC.Non-Qualified Stock Option Agreement • November 2nd, 2020 • Cerevel Therapeutics Holdings, Inc. • Pharmaceutical preparations
Pursuant to the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan as amended through the date hereof (the “Plan”), Cerevel Therapeutics Holdings, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.00001 per share (the “Stock”), of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan.
LEASELease • November 2nd, 2020 • Cerevel Therapeutics Holdings, Inc. • Pharmaceutical preparations • Massachusetts
THIS INSTRUMENT IS A LEASE, dated as of January 18th, 2019, in which the Landlord and the Tenant are the parties hereinafter named, and which relates to space in the building (the “Building”) located at 131 Dartmouth Street, Boston, Massachusetts. The parties to this instrument hereby agree with each other as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • November 2nd, 2020 • Cerevel Therapeutics Holdings, Inc. • Pharmaceutical preparations • Massachusetts
This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of November 23, 2018 by and between Cerevel Therapeutics, LLC (the “Company”) and Dr. N. Anthony Coles, Jr. (the “Executive”).
